|
±×¸°½ºÅä¾î |
[Á¦ÁÖ] ±×¸°½ºÅä¾î ¾à±¹°ü¸® ¸Å´ÏÀú ä¿ë°ø°í
Á¦ÁÖ ÀüÁö¿ª | Çз¹«°ü |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.05 |
|
|
Çѱ¹¾ËÄÜ |
[ALCON] Regulatory Affairs (RA) Specialist – °æ·Â
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
09.27 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
2023 »ó¹Ý±â º¸ÈÆƯº°Ã¤¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
1³â¡è |
ä¿ë½Ã |
02.17 |
|
|
ÁÖ½Äȸ»ç ¿¡½º¿¥¿¤Á¦´ÏÆ®¸® |
[SMLÁ¦´ÏÆ®¸®] RA(ÆÀÀå±Þ) °æ·ÂÁ÷ ¼ö½Ã ä¿ë °ø°í
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
09.07 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
BDºÎ¼ BD Associate ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.09 |
|
|
(ÁÖ)Ŭ·¡½Ã½º |
±³À°°³¹ßÆÀ °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
6³â¡è |
ä¿ë½Ã |
04.16 |
|
|
(ÁÖ)ÇÑ¿ï¹ÙÀÌ¿À |
(ÁÖ)ÇÑ¿ï¹ÙÀÌ¿À ¿µ¾÷ºÎ Á¤±ÔÁ÷ ä¿ë _ ü¿ÜÁø´ÜÀÇ·á±â±â(´ë
¼¿ï ÀüÁö¿ª, °æ±â ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.30 |
|
|
Çѱ¹¾ËÄÜ |
Çѱ¹¾ËÄÜ(ÁÖ) Field Service Engineer (½ÅÀÔ/°æ·Â)
¼¿ï ÀüÁö¿ª, °æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
AS/Á¤ºñ/¼ö¸®/¼³Ä¡ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
08.27 |
|
|
(ÁÖ)Å¥¶óƼ½º |
¹ÙÀÌ¿ÀÇ÷£Æ® QCÆÀ ¹Ì»ý¹°ÆÄÆ® Á¤±ÔÁ÷ ¸ðÁý
ÃæºÏ ûÁֽà Èï´ö±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.30 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
CMºÎ¼ CM Manager °æ·Â ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
1³â¡è |
ä¿ë½Ã |
11.27 |
|
|
À£Æ®ÁÖ½Äȸ»ç |
ÀÓ»ó½ÃÇè ¸Å´ÏÀú (Clinical Research Manager)
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
»ó½Ãä¿ë |
08.13 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSDµ¿¹°¾àÇ°]-Technical Marketing Manager-¹Ý·Áµ¿¹°,
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
08.13 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSD] MSL-ID/Vaccine
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
08.13 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
[LSK global PS] SP / ERA / PL ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
1³â¡è |
ä¿ë½Ã |
12.02 |
|
|
(ÁÖ)¾¾À¯¹Ú½º |
[Àü·«±âȹ±×·ì] ¾È¸éÀÎ½Ä ¼Ö·ç¼Ç ½Å»ç¾÷±âȹ ¹× ¿µ¾÷°ü¸®
¼¿ï ±Ýõ±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿µ¾÷°ü¸®/¿µ¾÷Áö¿ø |
3³â¡è |
ä¿ë½Ã |
07.27 |
|